Una Rigney

1.3k total citations
18 papers, 966 citations indexed

About

Una Rigney is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Una Rigney has authored 18 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Psychiatry and Mental health. Recurrent topics in Una Rigney's work include Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Una Rigney is often cited by papers focused on Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Una Rigney collaborates with scholars based in United Kingdom, Netherlands and Australia. Una Rigney's co-authors include I. Hindmarch, Neil Stanley, Gordon Mazibrada, Peggy Gray, Yvette A.M. Grimbergen, Ann Ashburn, Brian Wood, Bastiaan R. Bloem, Ruth Pickering and Graham Kerr and has published in prestigious journals such as Journal of Affective Disorders, Psychopharmacology and Movement Disorders.

In The Last Decade

Una Rigney

17 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Una Rigney United Kingdom 11 416 335 324 142 138 18 966
Diana Paleacu Israel 17 356 0.9× 672 2.0× 204 0.6× 35 0.2× 143 1.0× 26 1.2k
Danny Bega United States 17 293 0.7× 534 1.6× 124 0.4× 41 0.3× 80 0.6× 66 1.0k
Vikas Kotagal United States 25 314 0.8× 1.6k 4.7× 220 0.7× 46 0.3× 161 1.2× 59 2.3k
R. H. S. Mindham United Kingdom 16 295 0.7× 464 1.4× 58 0.2× 58 0.4× 88 0.6× 40 940
Antonina Luca Italy 22 212 0.5× 652 1.9× 33 0.1× 68 0.5× 66 0.5× 88 1.6k
Weerasak Muangpaisan Thailand 18 273 0.7× 237 0.7× 43 0.1× 41 0.3× 31 0.2× 69 1.0k
Peter Dal‐Bianco Austria 26 634 1.5× 124 0.4× 51 0.2× 89 0.6× 121 0.9× 75 1.5k
Paula B. Davis United States 6 663 1.6× 89 0.3× 110 0.3× 31 0.2× 129 0.9× 7 1.3k
Ghorban Taghizadeh Iran 16 252 0.6× 192 0.6× 170 0.5× 12 0.1× 95 0.7× 110 796
J.-F. Dartigues France 15 514 1.2× 638 1.9× 21 0.1× 41 0.3× 153 1.1× 19 2.0k

Countries citing papers authored by Una Rigney

Since Specialization
Citations

This map shows the geographic impact of Una Rigney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Una Rigney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Una Rigney more than expected).

Fields of papers citing papers by Una Rigney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Una Rigney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Una Rigney. The network helps show where Una Rigney may publish in the future.

Co-authorship network of co-authors of Una Rigney

This figure shows the co-authorship network connecting the top 25 collaborators of Una Rigney. A scholar is included among the top collaborators of Una Rigney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Una Rigney. Una Rigney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Wilding, John, Una Rigney, Betina T. Blak, et al.. (2019). Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 155. 107791–107791. 7 indexed citations
3.
Wilding, John, et al.. (2017). Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up. Primary care diabetes. 11(5). 437–444. 24 indexed citations
4.
Wilding, John, Thomas Godec, Kamlesh Khunti, et al.. (2017). Changes in HbA(1c) and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. 1 indexed citations
5.
Wilding, John, Clifford J. Bailey, Una Rigney, et al.. (2016). Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study. Diabetes Therapy. 7(4). 695–711. 21 indexed citations
6.
Blak, Betina T., et al.. (2015). Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class. International Journal of Clinical Practice. 70(1). 45–55. 6 indexed citations
7.
Bakhai, Ameet, et al.. (2012). Co‐administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiology and Drug Safety. 21(5). 485–493. 30 indexed citations
8.
Young, Allan H., et al.. (2011). Annual cost of managing bipolar disorder to the UK healthcare system. Journal of Affective Disorders. 133(3). 450–456. 52 indexed citations
9.
Pickering, Ruth, Yvette A.M. Grimbergen, Una Rigney, et al.. (2007). A meta‐analysis of six prospective studies of falling in Parkinson's disease. Movement Disorders. 22(13). 1892–1900. 425 indexed citations
10.
Stang, Paul, et al.. (2007). Persistence With Once-Daily Versus Twice-Daily Bupropion for the Treatment of Depression in a Large Managed-Care Population. American Journal of Therapeutics. 14(3). 241–246. 17 indexed citations
13.
Hindmarch, Ian, Alain Patat, Neil Stanley, Isabelle Paty, & Una Rigney. (2001). Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Human Psychopharmacology Clinical and Experimental. 16(2). 159–167. 39 indexed citations
14.
Hindmarch, Ian, Alain Patat, Neil Stanley, Isabelle Paty, & Una Rigney. (2001). Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Human Psychopharmacology Clinical and Experimental. 16(2). 159–167.
15.
Hindmarch, I., Una Rigney, Neil Stanley, & Mike Briley. (2000). Pharmacodynamics of milnacipran in young and elderly volunteers. British Journal of Clinical Pharmacology. 49(2). 118–125. 36 indexed citations
16.
Hindmarch, I., et al.. (2000). A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology. 149(3). 203–216. 190 indexed citations
17.
Rigney, Una, S. Kimber, & I. Hindmarch. (1999). The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytotherapy Research. 13(5). 408–415. 83 indexed citations
18.
Rigney, Una, S. Kimber, & I. Hindmarch. (1999). The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytotherapy Research. 13(5). 408–415. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026